Medifast (MED) Dividends payables (2015 - 2020)

Medifast has reported Dividends payables for 6 years, with the latest figure at $13.8 million in Q4 2020.

• For the quarter ending Q4 2020, Dividends payables rose 0.82% year-over-year to $13.8 million; the trailing twelve-month figure through Dec 2020 stood at $13.8 million (up 0.82% YoY), and the FY2020 full-year result was $13.8 million, up 0.82% from the prior year.
• Dividends payables for Q4 2020 stood at $13.8 million, up from $13.7 million in the prior quarter.
• The five-year high for Dividends payables was $13.8 million in Q4 2020, with the low at $4.0 million in Q4 2016.
• Historically, Dividends payables has averaged $9.4 million across 5 years, with a median of $9.1 million in 2018.
• Annual changes were most pronounced in 2017 — Dividends payables soared 51.15% — and 2020, when it rose 0.82%.
• Medifast's Dividends payables stood at $4.0 million in 2016, then jumped by 51.15% to $6.1 million in 2017, then jumped by 49.66% to $9.1 million in 2018, then jumped by 50.15% to $13.7 million in 2019, then climbed by 0.82% to $13.8 million in 2020.
• The last three Dividends payables figures came in at $13.8 million (Q4 2020), $13.7 million (Q4 2019), and $9.1 million (Q4 2018), per Business Quant data.